NCT02575092View on ClinicalTrials.gov

The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

4,000

Participants

Timeline

Start Date

November 1, 2015

Primary Completion Date

February 10, 2019

Study Completion Date

July 31, 2019

Conditions
HomocysteineCoronary DiseaseAngioplasty,Balloon,CoronaryContrast MediaNephropathyHypertension
Interventions
DRUG

Enalapril Maleate Tablets(as the program-based antihypertension)

DRUG

Enalapril Maleate and Folic Acid tablets(as the program-based antihypertension)

DRUG

Placebo

Trial Locations (1)

408099

TIAN Jie, Fuling

All Listed Sponsors
lead

Fuling Central Hospital of Chongqing City

OTHER

NCT02575092 - The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment | Biotech Hunter | Biotech Hunter